← Eichor
Study identifier: NCT06039306 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Perioperative Immunonutrition Under Enhanced Recovery After Surgery

Condition: Gynecological Cancer · Elective Surgery  ·  Sponsor: Universiti Putra Malaysia

PhaseNA
Planned participants106
Who can joinFemale, 18 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to compare the effect of perioperative immunonutrition supplement in gynecologic cancer patients. The main questions it aims to answer are: * is there any difference in the nutritional outcomes and functional outcomes between intervention and conventional groups? * is there any difference in the post-surgical outcomes between intervention and conventional groups? Participants (intervention) will be provided the immunonutrition supplement before and after operation. Researchers will compare intervention group with conventional group to see if there is any difference in postoperative outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

ChiouYi Ho  ·  0388925555  ·  agneshcy0326@gmail.com

Zulfitri 'Azuan Mat Daud  ·  zulfitri@upm.edu.my

Always discuss trial participation with your own doctor first.

Locations (1)

Institut Kanser NegaraPutrajaya, Putrajaya, MalaysiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06039306